Skip to content

The Effect of Contrast Media on Erythrocytes in Healthy Volunteers

The Effect of Low-Osmolar and Iso-Osmolar Contrast Media on Erythrocytes in Healthy Volunteers.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00285506
Enrollment
20
Registered
2006-02-02
Start date
2006-01-31
Completion date
2006-01-31
Last updated
2006-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Keywords

Healthy Volunteers

Brief summary

The purpose of the study is to test the effect that contrast media (dye) has on cellular integrity (structure)

Detailed description

The influence of several radiological contrast media on erythrocyte morphology and function has been investigated in the past (1). However, published data is sparse and does not include the assessment of iso-osmolar agents as compared to low-osmolar agents. In addition, the effect of the injection of contrast media at higher temperatures (i.e. \> room or body temperature), which may be beneficial for the rapid injection of more viscous contrast media at multi detector-row CT angiography, has never been evaluated. We intend to assess the hypothesis, that iso-osmolar contrast media (i.e. Visipaque) exerts less effect on erythrocyte morphology and function as compared to low-osmolar agents. In addition, we intend to identify the upper temperature limit, at which contrast media can be injected, without affecting erythrocyte integrity. Subjects will have up tp 400 mLs (approximately 26 tablespoons) of blood drawn. The blood will be kept at body temperature in a petri dish or similar container and exposed to contrast media (dye).

Interventions

None listed

Sponsors

GE Healthcare
CollaboratorINDUSTRY
Medical University of South Carolina
Lead SponsorOTHER

Study design

Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects must be at least 18 years old * Subjects must be at least 110lbs and

Exclusion criteria

* Subjects may not be pregnant * Subjects must not possess any medical conditions that would preclude them from participating

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026